This study examined the distribution and consumption of iron-folic acid tablets within antenatal care programs in 22 countries with high burdens of undernutrition. The analysis identifies where antenatal care-based distribution of iron-folic acid falters in each country, enabling policymakers to design and prioritize follow-up activities to more precisely identify barriers, an essential next step to improving iron-folic acid distribution through antenatal care.